This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Research

Relapse Prevention of Panic Disorder in Adult Outpatient Responders to Treatment With Venlafaxine Extended Release

James M. Ferguson, MD; Arif Khan, MD; Richard Mangano, PhD; Richard Entsuah, PhD; and Evan Tzanis, BA

Published: January 15, 2007

Article Abstract

Objective: To compare the long-term efficacy of venlafaxine extended release (ER) with placebo in preventing panic disorder relapse inoutpatient treatment responders.

Method: Outpatients aged >= 18 years who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for panic disorder with or without agoraphobia for at least the previous 3 months, with >= 6 full symptom panic attacks in the 2 weeks prior to screening and >= 3 in the 2 weeks before baseline and a Clinical Global Impressions-Severity of Illness rating >= 4 at screen were eligible to participate. Outpatients received flexible-dose (75-225 mg/day) venlafaxine ER for 12 weeks. Treatment responders were randomly assigned to venlafaxine ER or placebo for 26 weeks. Criteria for response were = 2 full symptom panic attacks per week for 2 consecutive weeks or discontinuation due to loss of effectiveness, was evaluated using Kaplan-Meier survival analysis. The study was conducted between December 2001 and August 2003.

Results: The intent-to-treat population had 291 patients in the open-label phase and 169 in the double-blind phase (placebo, N = 80; venlafaxine ER, N = 89; mean daily dose 165-171 mg). Time to relapse was significantly longer with venlafaxine ER than placebo (p < .001). All secondary measures of panic attack treatment efficacy, quality of life, and disability were significantly better with venlafaxine ER than placebo (p <= .005).

Conclusion: Venlafaxine ER was safe, well tolerated, and effective in preventing relapse in outpatients with panic disorder.

Volume: 68

Quick Links:

Continue Reading…

Subscribe to read the entire article


Buy this Article as a PDF